These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
201 related articles for article (PubMed ID: 19796106)
1. Vaccination strategies against hepatitis A in travelers older than 40 years: an economic evaluation. Costas L; Vilella A; Trilla A; Serrano B; Vera I; Roldán M; Sancho MP; Bayas JM; Gascón J; Costa J J Travel Med; 2009; 16(5):344-8. PubMed ID: 19796106 [TBL] [Abstract][Full Text] [Related]
2. [Seroprevalence of hepatitis A and cost evaluation of different vaccination strategies against hepatitis A virus in patients with chronic hepatitis C in France]. Rufat P; Dumouchel P; Cadranel JF Gastroenterol Clin Biol; 2002 Mar; 26(3):256-60. PubMed ID: 11981470 [TBL] [Abstract][Full Text] [Related]
3. Immunogenicity and safety of a virosomal hepatitis A vaccine (Epaxal) in the elderly. D'Acremont V; Herzog C; Genton B J Travel Med; 2006; 13(2):78-83. PubMed ID: 16553593 [TBL] [Abstract][Full Text] [Related]
4. Prevalence of hepatitis A antibodies in schoolchildren in Catalonia (Spain) after the introduction of universal hepatitis A immunization. Domínguez A; Bruguera M; Plans P; Costa J; Salleras L J Med Virol; 2004 Jun; 73(2):172-6. PubMed ID: 15122789 [TBL] [Abstract][Full Text] [Related]
5. Testing for antibody to hepatitis A to decrease the cost of hepatitis A prophylaxis with immune globulin or hepatitis A vaccines. Bryan JP; Nelson M Arch Intern Med; 1994 Mar; 154(6):663-8. PubMed ID: 8129500 [TBL] [Abstract][Full Text] [Related]
6. Seroprevalence of hepatitis A virus antibodies among a sample of Egyptian children. Al-Aziz AM; Awad MA East Mediterr Health J; 2008; 14(5):1028-35. PubMed ID: 19161074 [TBL] [Abstract][Full Text] [Related]
7. Cost-effective analysis of hepatitis A prevention in Ireland. Rajan E; Shattock AG; Fielding JF Am J Gastroenterol; 2000 Jan; 95(1):223-6. PubMed ID: 10638588 [TBL] [Abstract][Full Text] [Related]
8. Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus? Villar LM; de Melo MM; Calado IA; de Almeida AJ; Lampe E; Gaspar AM J Gastroenterol Hepatol; 2009 Feb; 24(2):238-42. PubMed ID: 19215334 [TBL] [Abstract][Full Text] [Related]
9. Epidemiology of hepatitis A and hepatitis E infection and their determinants in adult Chinese community in Hong Kong. Wong KH; Liu YM; Ng PS; Young BW; Lee SS J Med Virol; 2004 Apr; 72(4):538-44. PubMed ID: 14981755 [TBL] [Abstract][Full Text] [Related]
10. [Seroprevalence of antibodies against hepatitis A virus and hepatitis B virus in nonvaccinated adult population over 40 years of age]. Chlíbek R; Cecetková B; Smetana J; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2006 Aug; 55(3):99-104. PubMed ID: 16970073 [TBL] [Abstract][Full Text] [Related]
11. The effect of universal toddlers-only hepatitis A virus vaccination program on seropositivity rate in unvaccinated toddlers: evidence for reduced virus circulation in the community. Barkai G; Belmaker I; Givon-Lavi N; Dagan R Pediatr Infect Dis J; 2009 May; 28(5):391-3. PubMed ID: 19295466 [TBL] [Abstract][Full Text] [Related]
12. [Changes in seroepidemiology of hepatitis A virus infection in Catalonia in the period 1989-1996. Implications for new vaccination strategy]. Bruguera M; Salleras L; Plans P; Vidal J; Navas E; Domínguez A; Batalla J; Taberner JL; Espuñes J Med Clin (Barc); 1999 Mar; 112(11):406-8. PubMed ID: 10231772 [TBL] [Abstract][Full Text] [Related]
13. High prevalence of hepatitis A virus antibody among Bangladeshi children and young adults warrants pre-immunization screening of antibody in HAV vaccination strategy. Ahmed M; Munshi SU; Nessa A; Ullah MS; Tabassum S; Islam MN Indian J Med Microbiol; 2009; 27(1):48-50. PubMed ID: 19172060 [TBL] [Abstract][Full Text] [Related]
14. Prevalence of anti-hepatitis B and anti-hepatitis A antibodies among school aged children in Western Saudi Arabia. Jaber SM Saudi Med J; 2006 Oct; 27(10):1515-22. PubMed ID: 17013474 [TBL] [Abstract][Full Text] [Related]
15. Differences in hepatitis A seroprevalence among geographical regions in Turkey: a need for regional vaccination recommendations. Ceyhan M; Yildirim I; Kurt N; Uysal G; Dikici B; Ecevit C; Aydogan A; Koc A; Yasa O; Köseoğlu M; Onal K; Hacimustafaoglu M; Celebi S J Viral Hepat; 2008 Oct; 15 Suppl 2():69-72. PubMed ID: 18837839 [TBL] [Abstract][Full Text] [Related]
16. [Immunogenicity of vaccines against viral hepatitis A and B in the population above 40 years of age -- impact of risk factors]. Chlíbek R; Smetana J; Sindelár R; Cecetková B; Prymula R; Kohl I Epidemiol Mikrobiol Imunol; 2007 Aug; 56(3):119-28. PubMed ID: 17900060 [TBL] [Abstract][Full Text] [Related]
17. Hepatitis A seroprevalence in children and adults in Kiev City, Ukraine. Moisseeva AV; Marichev IL; Biloschitchkay NA; Pavlenko KI; Novik LV; Kovinko LV; Lyabis OI; Houillon G; Rasuli AM J Viral Hepat; 2008 Oct; 15 Suppl 2():43-6. PubMed ID: 18837833 [TBL] [Abstract][Full Text] [Related]
18. Hepatitis a in Korea: epidemiological shift and call for vaccine strategy. Lee D; Cho YA; Park Y; Hwang JH; Kim JW; Kim NY; Lee DH; Lee W; Jeong SH Intervirology; 2008; 51(2):70-4. PubMed ID: 18434743 [TBL] [Abstract][Full Text] [Related]
19. Person-to-person transmission of hepatitis A virus in an urban area of intermediate endemicity: implications for vaccination strategies. Victor JC; Surdina TY; Suleimenova SZ; Favorov MO; Bell BP; Monto AS Am J Epidemiol; 2006 Feb; 163(3):204-10. PubMed ID: 16339053 [TBL] [Abstract][Full Text] [Related]
20. Should one vaccinate patients with chronic liver disease for hepatitis A virus in India? Anand AC; Nagpal AK; Seth AK; Dhot PS J Assoc Physicians India; 2004 Oct; 52():785-7. PubMed ID: 15909855 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]